© The Financial Times Ltd 2016 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Feb 12, 2016, the consensus forecast amongst 23 polled investment analysts covering Procter & Gamble Co advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Jan 18, 2016. The previous consensus forecast advised investors to hold their position in Procter & Gamble Co.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 19 analysts offering 12 month price targets for Procter & Gamble Co have a median target of 84.00, with a high estimate of 94.00 and a low estimate of 75.00. The median estimate represents a 3.72% increase from the last price of 80.99. View Full Financials
In 2015, Procter & Gamble Co reported a dividend of 2.59 USD, which represents a 5.71% increase over last year. The 12 analysts covering the company expect dividends of 2.68 USD for the upcoming fiscal year, an increase of 3.55%. View Full Financials
|Div growth (TTM)||+5.71 %|
On Jan 26, 2016, Procter & Gamble Co reported 2nd quarter 2016 earnings of 1.04 per share. This result exceeded the 0.98 consensus of the 22 analysts covering the company and under-performed last year's 2nd quarter results by 1.89 %.
The next earnings announcement is expected on Apr 26, 2016. View Full Interim Financials
|Average growth rate||-0.10 %|
Procter & Gamble Co reported annual 2015 earnings of 4.02 per share on Jul 30, 2015. View Full Annual Financials
|Average growth rate||+0.53 %|
The Procter & Gamble Company had 2nd quarter 2016 revenues of 16.92bn. This missed the 16.94bn consensus estimate of the 19 analysts following the company. This was 16.10 % below the prior year's 2nd quarter results. View Full Interim Financials
|Average growth rate||-4.18 %|
The Procter & Gamble Company had revenues for the full year 2015 of 76.28bn. This was 8.17 % below the prior year's results. View Full Annual Financials
|Average growth rate||-1.88 %|